Modelling the Effectiveness of Ibrutinib Versus Rituximab-Based Chemotherapy Regimens in Relapsed/Refractory Mantle Cell Lymphoma
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.2212
https://www.valueinhealthjournal.com/article/S1098-3015(16)33578-1/fulltext
Title :
Modelling the Effectiveness of Ibrutinib Versus Rituximab-Based Chemotherapy Regimens in Relapsed/Refractory Mantle Cell Lymphoma
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33578-1&doi=10.1016/j.jval.2016.09.2212
First page :
A733
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2099